PROVIDENCE – Rubius Therapeutics Inc. has appointed Natalie Holles to its board of directors and Greg Whitehead as senior vice president and chief quality officer. Rubius, based in Cambridge, Mass., but with a facility under renovation in Smithfield, is a clinical-stage biopharmaceutical company generating red blood cells and bioengineering them into a new class of…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.